Applying Advanced Technology in CML Therapeutics to Boost Market Growth: Ken Research Buy Now Chronic myelocytic leukemia (CML) affects adult population between the ages of 40 and 60 and is uncommon in children younger than 10 years. CML is detected based on a simple blood test that exhibits an abnormally high count of white blood cells. Chronic myelocytic leukemia is usually a rearrangement of two particular chromosomes… Read More »